Vestal Point Capital’s MacroGenics MGNX Stock Holding History

Vestal Point Capital’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-280,000	Closed	-$809K	–	83
2026 Q1	$809K	Hold	280,000	–	–	0.02%	88
2025 Q4	$451K	Hold	280,000	–	–	0.02%	76
2025 Q3	$470K	Hold	280,000	–	–	0.02%	79
2025 Q2	$339K	Hold	280,000	–	–	0.02%	70
2025 Q1	$356K	Hold	280,000	–	–	0.03%	61
2024 Q4	$910K	Sell	280,000 -550,000	-66%	-$1.98M	0.05%	71
2024 Q3	$2.73M	Buy	830,000 +30,000	+4%	+$117K	0.21%	60
2024 Q2	$3.4M	Buy	800,000 +75,000	+10%	+$730K	0.25%	49
2024 Q1	$10.7M	Buy	+725,000	New	+$11M	0.88%	29

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vestal Point Capital's MGNX Position: Q2 2026 in Review

Vestal Point Capital sold out of MacroGenics (MGNX) in Q2 2026, closing a stake of 280,000 shares — an estimated $809K sold.

Vestal Point Capital first reported a position in MGNX in Q1 2024 and held it in 9 quarters. The position peaked at $10.7M in Q1 2024. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Vestal Point Capital reported no remaining MacroGenics position as of Q2 2026 after selling out during the quarter.
Vestal Point Capital sold 280,000 MacroGenics shares in Q2 2026, an estimated $809K.
Vestal Point Capital first reported a position in MacroGenics in Q1 2024 and held it in 9 quarters.
Vestal Point Capital's MacroGenics position peaked at $10.7M in Q1 2024.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Vestal Point Capital's 13F filing for Q2 2026, filed 14 Aug 2026.